Industry Identifies Top 10 Quality Metrics For FDA’s Proposed Monitoring Program

Washington Drug Letter
A group of pharmaceutical representatives has recommended 10 product and site quality metrics that the FDA should consider collecting from manufacturers, helping the agency shape its new quality metrics program.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00